Grupo Espanol De Trabajo En Enfermedad De Crohn y Colitis Ulcerosa
- Address
- Gran Via 81
Sponsor Overview
Specializations
Inflammatory Bowel Disease
The sponsor is active in inflammatory bowel disease research with a clear focus on ulcerative colitis, particularly in patients with long-standing disease control and older age groups. Its clinical interests center on disease stability, relapse prevention, and treatment decisions in chronic intestinal inflammation.
- Ulcerative colitis
- Inflammatory bowel disease
- Chronic intestinal inflammation
Research activity is concentrated in Spain through a network of collaborating sites, reflecting a focused clinical interest in managing persistent gastrointestinal inflammation within specialist care settings.
Maintenance Therapy and Treatment Withdrawal
Clinical research activity includes questions around maintenance therapy in ulcerative colitis, especially the consequences of stopping long-term immunosuppressant treatment after sustained remission. The therapeutic emphasis is on balancing ongoing disease control with treatment discontinuation in selected patients.
- Maintenance treatment
- Immunosuppressant discontinuation
- Long-term remission
The sponsor’s trial portfolio highlights interest in recurrence risk after withdrawal of thiopurines and in identifying patients who may remain stable without continued immunomodulatory therapy.
Elderly Patient Care
A distinct area of interest is the management of elderly patients with ulcerative colitis, where age-related treatment considerations intersect with prolonged remission and medication safety. The research focus addresses clinical decision-making in older adults living with chronic inflammatory disease.
- Older adults
- Age-related treatment decisions
- Remission in older patients
This area reflects attention to the therapeutic needs of patients in later life who may require individualized approaches to gastroenterology care and long-term medication management.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Mesalazine Monotherapy Versus Thiopurine Continuation in Older Patients with Ulcerative Colitis in Sustained Remission: Multicenter Randomized Trial |  Spain | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 12 sites across their trial portfolio.
Therapeutic Focus
- 1.Digestive System Diseases1 trial280 other sponsors
Partnered Research Centres
12 centres- Address
- Avenida De Las Islas Baleares 3, 09006 Burgos
- Address
- Carretera De Cirera 230, 08304 Mataró
- Address
- Calle De San Antonio No 32, 08221 Terrassa
- Address
- Paseo De La Castellana 261, 28046 Madrid
- Address
- Estrada Clara Campoamor No 341, 36312 Vigo
- Address
- Calle Villarroel 170, 08036 Barcelona
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Grupo Espanol De Trabajo En Enfermedad De Crohn y Colitis Ulcerosa.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.